In another clinical trial of CD19 CAR-T cells in patients with acute lymphoblastic leukemia, 3 CRS-related deaths observed after CD19 CAR-T cells were infused with a high dose [43]. The gene discussed is CD19; the disease is congenital rubella syndrome.